Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of Enanta Pharmaceuticals. A complete text table follows the diagram.
Antiviral medicines, licensing, and clinical development support Enanta's research platform.
Swipe to explore
The operating total is tied to the filing; the destination is an editorial label for the disclosed business engine, with no invented segment allocation.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Reported operating total | 1 | $28.6M | Directly reported in the downloaded 10-Q |
| antiviral therapeutics platform | 2 | $28.6M | Antiviral medicines, licensing, and clinical development support Enanta's research platform. |
| From | To | Value |
|---|---|---|
| Reported operating total | antiviral therapeutics platform | $28.6M |